Skip to main content
OpenTrials
Completed

NCT Number: NCT06086899

The Efficacy and Safety of Early MSAT on Radiating Pain in the Upper Extremity

This study is a double blind, randomized controlled trail. condition/disease: radiating pain in the upper extremity. treatment/intervention: motion style acupuncture treatment

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–69 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jaseng Hospital of Korean Medicine

Seoul, Gangnam-Gu, 135-896, South Korea

About this study

"Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation. This treatment is known to relieve the pain and increase the range of motion(ROM). However, there has been no specific value for the effect of this treatment.

So, we conducted a randomized controlled trials to verify the efficacy and safety of MSAT on radiating pain in the upper extremity. From October 2023 to December 2024, we collected 100 inpatients who were suffered from radiating pain in the upper extremity with the numeric rating scale(NRS) over 5 after injury by acute traffic accident(TA). For experimental group(n=50), we conducted MSAT three times(on 2nd, 3rd and 4th day of hospitalization) and other Korean medical treatment. For control group(n=50), just Korean medical treatment except MSAT was conducted. For these two groups, we compared NRS, Visual Analogue Scale(VAS), Neck Disability Index(NDI), C-SPINE MRI, EuroQol 5-Dimension (EQ-5D) and Patient Global Impression of Change (PGIC)."

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 19-69 years on the date they sign the consent form.
  • Patients who are suffered byradiating pain in the upper extremity that occurred within 3 days after traffic accident.
  • Patients who are hospitalized due to traffic accident.
  • Patients with NRS of radiating pain ≥ 5.
  • Patients who provide consent to participate in the trial and return the informed consent form.

Exclusion criteria

  • Patients with a specific serious disease that may cause radiating pain: malignancy, spondylitis, inflammatory spondylitis, etc.
  • Patients with progressive neurological deficits or with severe neurological symptoms.
  • Patients with medical history of cervical surgery or thoracic surgery within the last three weeks.
  • Patients who have radiating pain in upper extremity before the traffic accident.
  • Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
  • Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study.
  • If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease.
  • Patients who are pregnant or planning to become pregnant.
  • Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
  • Patients who are difficult to complete the research participation agreement.
  • Other patients whose participation in the trial is judged by a researcher to be problematic.

Treatment and study plan

Cervical motion style acupuncture treatment(Trapezius, Rhomboid, Scalene)

Procedure

Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation

Korean medical treatment

Procedure

acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine

Primary outcomes

  1. Numeric Rating Scale(NRS) of radiating pain

    Time frame: Screening, Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

    NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their leg pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

Secondary outcomes

  1. Location of Radiating pain

    Time frame: Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

    The location of radiating pain varies depending on the nerve. The assessor will ask patients where the pain occur.

  2. VAS of Radiating pain

    Time frame: Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

    VAS is an assessment index in which the patient records their pain on a 100mm line from 'no pain' at one end, and 'the most severe pain imaginable' at the other end.

  3. C-SPINE MRI

    Time frame: Taken within ±14 days of hospitalization

    We will examine the results of patients who underwent MRI. The investor will conduct whether or not MRI was performed, date of operation, presence of cervical disc herniation, grade of cervical disc herniation, area of cervical disc herniation, classification of disc degeneration, presence of stenosis.

  4. NRS of Neck pain

    Time frame: Baseline(day2), day3, day4, day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

    NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their leg pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

  5. NDI

    Time frame: Baseline(day2), day5, Discharge 1 day, 1month after enrollment, 3month after enrollment

    NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their leg pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

  6. EQ-5D

    Time frame: Baseline(day2), day5, Discharge 1 day, 1month after enrollment, 3 months after enrollment

    The EQ-5D is a method of indirectly calculating the weights of certain health states for quality of life after a multidimensional investigation of health states, and is the most widely used instrument for this purpose. The EQ-5D consists of 5 questions about current health state (mobility, self-care, usual activities, pain, anxiety/depression), and each question is scored on a 5-point Likert scale (1=no problems, 3=moderate problems, 5=severe problems). In this study, the investigators will use the Korean version of the EQ-5D, which has been demonstrated to be valid.

  7. PGIC

    Time frame: day5, Discharge 1 day, 1month after enrollment, 3 months after enrollment

    The PGIC is an index that assesses improvements in functional limitation caused by whiplash injury. Participants rate the improvement in functional limitations after treatment on a 7-point Likert scale (1=Very much improved, 4=No change, 7=Very much worse). This index was originally developed for use in Psychology, but is currently used in various other medical fields to assess improvements in pain

Sponsors and collaborators

Lead sponsor

Jaseng Medical Foundation

Other

Registry information

Official study title

The Effect of Early MSAT Treatment on Radiating Pain in the Upper Extremity Caused by Traffic Accidents: A Pragmatic Randomized Controlled Trial

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 17, 2023
Registry last updated
Sep 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.